Skip to main content
. 2021 Apr 27;11(5):785. doi: 10.3390/diagnostics11050785

Table 1.

Demographic characteristics of eligible participants for the early detection of chronic obstructive pulmonary disease (COPD).

Characteristics Non-COPD COPD Total p-Value
Sample size 267 103 370 -
Age (mean ± SD) 59.0 ± 9.0 65.7 ± 9.8 60.9 ± 9.7 <0.001
<55 years 93 (34.8%) 17 (16.5%) 110 (29.7%) <0.001
55–59 years 46 (17.2%) 9 (8.7%) 55 (14.9%)
60–64 years 56 (21%) 17 (16.5%) 73 (19.7%)
≥65 years 72 (27%) 60 (58.3%) 132 (35.7%)
Gender
Male 253 (94.8%) 96 (93.2%) 349 (94.3%) 0.536
Female 14 (5.2%) 7 (6.8%) 21 (5.7%)
BMI 25.81 ± 3.86 24.38 ± 4.13 25.41 ± 3.98 0.001
Cough
No 24 (9.0%) 4 (3.9%) 28 (7.6%) 0.096
Yes 243 (91.0%) 99 (96.1%) 342 (92.4%)
Phlegm
No 30 (11.2%) 9 (8.7%) 39 (10.5%) 0.483
Yes 237 (88.8%) 94 (91.3%) 331 (89.5%)
Breathless
No 91 (34.1%) 24 (23.3%) 115 (31.1%) 0.045
Yes 176 (65.9%) 79 (76.7%) 255 (68.9%)
CAT 9 ± 6 12 ± 7 10 ± 6
0–9 160 (59.9%) 43 (41.7%) 203 (54.9%) 0.001
10–19 94 (35.2%) 44 (42.7%) 138 (37.3%)
20–29 12 (4.5%) 15 (14.6%) 27 (7.3%)
30–40 1 (0.4%) 1 (1.0%) 2 (0.5%)
Smoking pack-years 39.4 ± 27.5 48.6 ± 29.3 42.6 ± 28.3 0.001
<50 216 (80.9%) 67 (65.0%) 283 (76.5%) <0.001
≥50 51(19.1%) 36 (35.0%) 87 (23.5%)
Pre-bronchodilator FEV1/FVC determined using Spirobank Smart 81.78 ± 7.44 63.57 ± 13.37 76.71 ± 12.49 <0.001
Post-bronchodilator FEV1/FVC determined using a diagnostic spirometer 81.28 ± 7.19 59.06 ± 9.04 75.1 ± 12.62 <0.001